Company news

Immuron Limited news in 2022

Immuron Limited's news releases, calls and decks from 2022, newest first.

View company

Immuron Receives FDA Approval for Travelan IND Application

December 22, 2022

Immuron completes strategic investment in Ateria Health

November 15, 2022

IMC investment in leading gut health biotech Ateria Health

October 13, 2022

Immuron Update on IMM-124E SARS-CoV-2 Research

August 18, 2022

North American Travelan Sales up 494%, Global sales up 431%

July 10, 2022

European Patent Notification on Drug Composition for CDI

July 6, 2022

US DoD NMRC files IND application with FDA

May 11, 2022

US DoD Uniformed Services University Clinical Update

May 9, 2022

Appointment of Mr Steven Lydeamore as Chef Executive Officer

May 5, 2022

Immuron Q3 Global Sales up 216% YoY

April 27, 2022

Half Yearly Report and Accounts

February 25, 2022

Response to ASX Query

January 24, 2022

Immuron Receives European Patent on Drug to Treat Diarrhea

January 12, 2022

Decks in 2022